Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm

Enveloped viruses encode specialized fusion proteins which promote the merger of viral and cell membranes, permitting the cytosolic release of the viral cores. Understanding the molecular details of this process is essential for antiviral strategies. Recent structural studies revealed a stunning diversity of viral fusion proteins in their native state. In spite of this diversity, the post-fusion structures of these proteins share a common trimeric hairpin motif in which the amino- and carboxy-terminal hydrophobic domains are positioned at the same end of a rod-shaped molecule. The converging hairpin motif, along with biochemical and functional data, implies that disparate viral proteins promote membrane merger via a universal "cast-and-fold" mechanism. According to this model, fusion proteins first anchor themselves to the target membrane through their hydrophobic segments and then fold back, bringing the viral and cellular membranes together and forcing their merger. However, the pathways of protein refolding and the mechanism by which this refolding is coupled to membrane rearrangements are still not understood. The availability of specific inhibitors targeting distinct steps of HIV-1 entry permitted the identification of key conformational states of its envelope glycoprotein en route to fusion. These studies provided functional evidence for the direct engagement of the target membrane by HIV-1 envelope glycoprotein prior to fusion and revealed the role of partially folded pre-hairpin conformations in promoting the pore formation.

[1]  M. Kielian,et al.  Differential roles of two conserved glycine residues in the fusion peptide of Semliki Forest virus. , 2001, Virology.

[2]  Winfried Weissenhorn,et al.  Virus membrane fusion , 2007, FEBS Letters.

[3]  J. Hoxie,et al.  The Stoichiometry of Trimeric SIV Glycoprotein Interaction with CD4 Differs from That of Anti-envelope Antibody Fab Fragments* , 2001, The Journal of Biological Chemistry.

[4]  William C. Olson,et al.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.

[5]  P. Paterlini-Bréchot,et al.  Cytobiological consequences of calcium-signaling alterations induced by human viral proteins. , 2006, Biochimica et biophysica acta.

[6]  G. Melikyan,et al.  Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane. , 2005, Molecular biology of the cell.

[7]  M. Liao,et al.  Functions of the Stem Region of the Semliki Forest Virus Fusion Protein during Virus Fusion and Assembly , 2006, Journal of Virology.

[8]  W. Greene,et al.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.

[9]  D. Covell,et al.  pH-dependent fusion of vesicular stomatitis virus with Vero cells. Measurement by dequenching of octadecyl rhodamine fluorescence. , 1987, The Journal of biological chemistry.

[10]  R. Epand,et al.  Fusion peptides and the mechanism of viral fusion. , 2003, Biochimica et biophysica acta.

[11]  J. Nagle,et al.  HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates. , 2007, Biophysical journal.

[12]  T. Dragic,et al.  An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry. , 2006, Virology.

[13]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[14]  Renate Kunert,et al.  Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides , 2004, Journal of Virology.

[15]  M. Martin,et al.  Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1 , 1994, Journal of virology.

[16]  M. Kozlov,et al.  Membranes of the world unite! , 2006, The Journal of cell biology.

[17]  S. A. Gallo,et al.  The HIV Env-mediated fusion reaction. , 2003, Biochimica et biophysica acta.

[18]  E. Delwart,et al.  A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Melikyan,et al.  The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. , 2000, Molecular biology of the cell.

[20]  P. Bronk,et al.  Multiple Local Contact Sites are Induced by GPI‐Linked Influenza Hemagglutinin During Hemifusion and Flickering Pore Formation , 2000, Traffic.

[21]  R. Blumenthal,et al.  Role of the Membrane-Proximal Domain in the Initial Stages of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Mediated Membrane Fusion , 1999, Journal of Virology.

[22]  R. Ruigrok,et al.  Photolabeling Identifies a Putative Fusion Domain in the Envelope Glycoprotein of Rabies and Vesicular Stomatitis Viruses (*) , 1995, The Journal of Biological Chemistry.

[23]  R. Doms Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. , 2000, Virology.

[24]  F. Diaz-Griffero,et al.  Endocytosis Is a Critical Step in Entry of Subgroup B Avian Leukosis Viruses , 2002, Journal of Virology.

[25]  A. Helenius,et al.  Rab7 Associates with Early Endosomes to Mediate Sorting and Transport of Semliki Forest Virus to Late Endosomes , 2005, PLoS biology.

[26]  P S Kim,et al.  Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.

[27]  R. Lamb,et al.  Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures , 2005, Virology.

[28]  S. Harrison Viral membrane fusion , 2008, Nature Structural &Molecular Biology.

[29]  C. Weiss,et al.  Mutational Analysis of Residues in the Coiled-Coil Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 , 1998, Journal of Virology.

[30]  H. Katinger,et al.  Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. , 2007, Biochemistry.

[31]  D. Kabat,et al.  Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency Virus , 2005, Journal of Virology.

[32]  John P. Moore,et al.  Ternary Complex Formation of Human Immunodeficiency Virus Type 1 Env, CD4, and Chemokine Receptor Captured as an Intermediate of Membrane Fusion , 2005, Journal of Virology.

[33]  Michael M. Kozlov,et al.  Membrane Hemifusion: Crossing a Chasm in Two Leaps , 2005, Cell.

[34]  A. Pelchen-Matthews,et al.  Endocytosis in Viral Replication , 2000, Traffic.

[35]  L. Chernomordik,et al.  Biomembrane fusion: a new concept derived from model studies using two interacting planar lipid bilayers. , 1987, Biochimica et biophysica acta.

[36]  Min Lu,et al.  Structural and Functional Analysis of Interhelical Interactions in the Human Immunodeficiency Virus Type 1 gp41 Envelope Glycoprotein by Alanine-Scanning Mutagenesis , 2001, Journal of Virology.

[37]  H. Kräusslich,et al.  Involvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 Entry , 2005, Journal of Virology.

[38]  N. Demaurex,et al.  Endosome-to-cytosol transport of viral nucleocapsids , 2005, Nature Cell Biology.

[39]  G. Melikyan,et al.  A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle. , 2004, Biophysical journal.

[40]  H. Kräusslich,et al.  Interactions of human retroviruses with the host cell cytoskeleton. , 2006, Current opinion in microbiology.

[41]  A. Trkola,et al.  Estimating the Stoichiometry of Human Immunodeficiency Virus Entry , 2008, Journal of Virology.

[42]  P. S. Kim,et al.  A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. , 1995, Biochemistry.

[43]  Shibo Jiang,et al.  Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational Changes , 2004, Journal of Virology.

[44]  Joseph Sodroski,et al.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.

[45]  L. Chernomordik,et al.  Viral and Developmental Cell Fusion Mechanisms: Conservation and Divergence , 2008, Developmental Cell.

[46]  B. Sodeik,et al.  Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell , 2006, Cellular microbiology.

[47]  C. Broder,et al.  Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion. , 2000, Experimental and molecular pathology.

[48]  A. Sanchez,et al.  Mutational Analysis of the Putative Fusion Domain of Ebola Virus Glycoprotein , 1999, Journal of Virology.

[49]  V. Markin,et al.  Membrane fusion: stalk model revisited. , 2002, Biophysical journal.

[50]  M. Imai,et al.  Dual Wavelength Imaging Allows Analysis of Membrane Fusion of Influenza Virus inside Cells , 2006, Journal of Virology.

[51]  L. Tamm Hypothesis: spring-loaded boomerang mechanism of influenza hemagglutinin-mediated membrane fusion. , 2003, Biochimica et biophysica acta.

[52]  Ji Ming Wang,et al.  Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells , 2002, Journal of Virology.

[53]  S. Blacklow,et al.  The Mature Avian Leukosis Virus Subgroup A Envelope Glycoprotein Is Metastable, and Refolding Induced by the Synergistic Effects of Receptor Binding and Low pH Is Coupled to Infection , 2004, Journal of Virology.

[54]  J. Lineberger,et al.  Nef Does Not Affect the Efficiency of Human Immunodeficiency Virus Type 1 Fusion with Target Cells , 2003, Journal of Virology.

[55]  M. Kozlov,et al.  [Possible mechanism of membrane fusion]. , 1983, Biofizika.

[56]  F S Cohen,et al.  A quantitative model for membrane fusion based on low-energy intermediates , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. S. Kim,et al.  A spring-loaded mechanism for the conformational change of influenza hemagglutinin , 1993, Cell.

[58]  D. Kabat,et al.  An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations. , 2007, Journal of molecular biology.

[59]  M. Kielian Class II virus membrane fusion proteins. , 2006, Virology.

[60]  Nathan M. Sherer,et al.  Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells , 2005, The Journal of cell biology.

[61]  S. Durell,et al.  What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review). , 1997, Molecular membrane biology.

[62]  S. Goff,et al.  Retroviral proteins that interact with the host cell cytoskeleton. , 2007, Current opinion in immunology.

[63]  Yonathan Kozlovsky,et al.  Stalk model of membrane fusion: solution of energy crisis. , 2002, Biophysical journal.

[64]  P. Earl,et al.  Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers , 1992, Journal of Virology.

[65]  J. Zimmerberg,et al.  Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines , 2001, The Journal of cell biology.

[66]  S. A. Gallo,et al.  Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion , 2006, Retrovirology.

[67]  J. Zimmerberg,et al.  Bending membranes to the task: structural intermediates in bilayer fusion. , 1995, Current opinion in structural biology.

[68]  J. Lepault,et al.  Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited , 2008, Cellular and Molecular Life Sciences.

[69]  G. Melikyan,et al.  HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. , 2003, Molecular biology of the cell.

[70]  S. Pelletier,et al.  Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers , 1996, The Journal of cell biology.

[71]  F S Cohen,et al.  A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. , 1999, Molecular biology of the cell.

[72]  Q. Sattentau,et al.  Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding , 1991, The Journal of experimental medicine.

[73]  S. Durell,et al.  Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events , 1996, The Journal of cell biology.

[74]  G. Lewis,et al.  Antigenic Properties of the Human Immunodeficiency Virus Transmembrane Glycoprotein during Cell-Cell Fusion , 2002, Journal of Virology.

[75]  J. Binley,et al.  The Cytoplasmic Tail Slows the Folding of Human Immunodeficiency Virus Type 1 Env from a Late Prebundle Configuration into the Six-Helix Bundle , 2005, Journal of Virology.

[76]  J. Sodroski,et al.  Stoichiometry of Envelope Glycoprotein Trimers in the Entry of Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.

[77]  S. A. Gallo,et al.  HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. , 2001, Biochemistry.

[78]  G. Whittaker,et al.  Differential Requirements of Rab5 and Rab7 for Endocytosis of Influenza and Other Enveloped Viruses , 2003, Traffic.

[79]  J. White,et al.  Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. , 1990, Biochemistry.

[80]  C. Broder,et al.  Inhibitors of Protein-Disulfide Isomerase Prevent Cleavage of Disulfide Bonds in Receptor-bound Glycoprotein 120 and Prevent HIV-1 Entry* , 2002, The Journal of Biological Chemistry.

[81]  Anna K Bellamy-McIntyre,et al.  Functional Links between the Fusion Peptide-proximal Polar Segment and Membrane-proximal Region of Human Immunodeficiency Virus gp41 in Distinct Phases of Membrane Fusion* , 2007, Journal of Biological Chemistry.

[82]  I. Jones,et al.  Protein-disulfide Isomerase-mediated Reduction of Two Disulfide Bonds of HIV Envelope Glycoprotein 120 Occurs Post-CXCR4 Binding and Is Required for Fusion* , 2003, The Journal of Biological Chemistry.

[83]  R. Dwek,et al.  N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure , 1996, Journal of virology.

[84]  Nga Nguyen,et al.  Peptides Trap the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion Intermediate at Two Sites , 2003, Journal of Virology.

[85]  G. Whittaker,et al.  Dissecting virus entry via endocytosis. , 2002, The Journal of general virology.

[86]  J. Sodroski,et al.  Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events , 1992, Journal of virology.

[87]  G. Melikyan,et al.  The process of membrane fusion: Nipples, hemifusion, pores, and pore growth , 2002 .

[88]  K. Salzwedel,et al.  Direct Evidence that C-Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Entry Bind to the gp41 N-Helical Domain in Receptor-Activated Viral Envelope , 2003, Journal of Virology.

[89]  É. Cohen,et al.  Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry , 2006, Retrovirology.

[90]  T. Hope,et al.  Physiological Levels of Virion-Associated Human Immunodeficiency Virus Type 1 Envelope Induce Coreceptor-Dependent Calcium Flux , 2006, Journal of Virology.

[91]  M. Roth,et al.  Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. , 1999, Molecular biology of the cell.

[92]  R. Blumenthal,et al.  Conformational changes and fusion activity of vesicular stomatitis virus glycoprotein: [125I]iodonaphthyl azide photolabeling studies in biological membranes. , 1997, Biochemistry.

[93]  L. Hernandez,et al.  Mutational Analysis of the Candidate Internal Fusion Peptide of the Avian Leukosis and Sarcoma Virus Subgroup A Envelope Glycoprotein , 1998, Journal of Virology.

[94]  Michael J Rust,et al.  Ligands for Clathrin-Mediated Endocytosis Are Differentially Sorted into Distinct Populations of Early Endosomes , 2006, Cell.

[95]  L. Chernomordik,et al.  Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion. , 2000, Molecular biology of the cell.

[96]  M. Alizon,et al.  Rescue of HIV-1 Receptor Function through Cooperation between Different Forms of the CCR5 Chemokine Receptor* , 2002, The Journal of Biological Chemistry.

[97]  A. Kolokoltsov,et al.  Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. , 2006, Journal of virological methods.

[98]  G. Melikyan,et al.  Evolution of intermediates of influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements of pore formation. , 2001, Biophysical journal.

[99]  G. Melikyan,et al.  Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion , 2000, The Journal of cell biology.

[100]  J. Bess,et al.  Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling. , 2002, Virology.

[101]  Kathryn L. Schornberg,et al.  Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein , 2006, Journal of Virology.

[102]  M. Liao,et al.  Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion , 2005, The Journal of cell biology.

[103]  J. Young,et al.  Low pH Is Required for Avian Sarcoma and Leukosis Virus Env-Induced Hemifusion and Fusion Pore Formation but Not for Pore Growth , 2004, Journal of Virology.

[104]  Y. Shai,et al.  Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. , 2000, Journal of molecular biology.

[105]  R. Lamb,et al.  Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion , 2001, The EMBO journal.

[106]  G. Melikyan,et al.  The Energetics of Membrane Fusion from Binding, through Hemifusion, Pore Formation, and Pore Enlargement , 2004, The Journal of Membrane Biology.

[107]  F. Richards,et al.  The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. , 1991, The Journal of biological chemistry.

[108]  B. Fehse,et al.  Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry , 2001, Journal of Virology.

[109]  J. Cunningham,et al.  Retroviral Entry Mediated by Receptor Priming and Low pH Triggering of an Envelope Glycoprotein , 2000, Cell.

[110]  G. Melikyan,et al.  Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement. , 2003, Virology.

[111]  S. Whelan,et al.  Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection , 2005, Science.

[112]  K. Salzwedel,et al.  Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[113]  Shibo Jiang,et al.  The function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope protein‐mediated cell fusion , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[114]  S. A. Gallo,et al.  Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41. , 2004, Biochemistry.

[115]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[116]  R. Lamb,et al.  Structural basis of viral invasion: lessons from paramyxovirus F. , 2007, Current opinion in structural biology.

[117]  A. Helenius,et al.  Vesicular Stomatitis Virus Entry Host Cell Factors and Functions Involved In , 2022 .

[118]  D. Chan,et al.  The Prefusogenic Intermediate of HIV-1 gp41 Contains Exposed C-peptide Regions* , 2003, The Journal of Biological Chemistry.

[119]  J. Skehel,et al.  Coiled Coils in Both Intracellular Vesicle and Viral Membrane Fusion , 1998, Cell.

[120]  D. Grainger,et al.  Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction , 2005, Retrovirology.

[121]  C. Broder,et al.  The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. , 2007, Virus research.

[122]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[123]  Kozlov Mm,et al.  Possible mechanism of membrane fusion , 1983 .

[124]  Thorsten Lang,et al.  Membrane fusion. , 2002, Current opinion in cell biology.

[125]  Mark Marsh,et al.  Virus Entry: Open Sesame , 2006, Cell.

[126]  G. Chang,et al.  A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles. , 2008, Virology.

[127]  Michael J Rust,et al.  Visualizing infection of individual influenza viruses , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[128]  A. Kolokoltsov,et al.  Rapid and Sensitive Detection of Retrovirus Entry by Using a Novel Luciferase-Based Content-Mixing Assay , 2004, Journal of Virology.

[129]  Joseph Sodroski,et al.  Stoichiometry of Antibody Neutralization of Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.

[130]  M. Kielian,et al.  Fusion Induced by a Class II Viral Fusion Protein, Semliki Forest Virus E1, Is Dependent on the Voltage of the Target Cell , 2007, Journal of Virology.

[131]  C. Weiss,et al.  Capture of an early fusion-active conformation of HIV-1 gp41 , 1998, Nature Structural Biology.

[132]  Kathryn L. Schornberg,et al.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. , 2008, Critical reviews in biochemistry and molecular biology.

[133]  K. Stiasny,et al.  Effect of Membrane Curvature-Modifying Lipids on Membrane Fusion by Tick-Borne Encephalitis Virus , 2004, Journal of Virology.

[134]  J. Lepault,et al.  Visualization of the Target-Membrane-Inserted Fusion Protein of Semliki Forest Virus by Combined Electron Microscopy and Crystallography , 2003, Cell.

[135]  R. Blumenthal,et al.  The role of glycosphingolipids in HIV signaling, entry and pathogenesis , 2003, Glycoconjugate Journal.

[136]  S. Matsuyama,et al.  Sequential Roles of Receptor Binding and Low pH in Forming Prehairpin and Hairpin Conformations of a Retroviral Envelope Glycoprotein , 2004, Journal of Virology.

[137]  Don C. Wiley,et al.  Structure of an unliganded simian immunodeficiency virus gp120 core , 2005, Nature.

[138]  J. Skehel,et al.  Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin , 1995, Journal of virology.

[139]  W. Ou,et al.  Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion. , 2006, Virology.

[140]  S. Roche,et al.  Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. , 2002, Virology.

[141]  S. Durell,et al.  Dilation of the Human Immunodeficiency Virus–1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41 , 1998, The Journal of cell biology.

[142]  L. Tamm,et al.  Viral Fusion Peptides: A Tool Set to Disrupt and Connect Biological Membranes , 2000, Bioscience reports.

[143]  P. Klasse Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. , 2007, Virology.

[144]  M. Roth,et al.  A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. , 2000, Molecular biology of the cell.

[145]  R. Blumenthal,et al.  Varying effects of temperature, Ca2+ and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins , 2000, FEBS letters.

[146]  R. Blumenthal,et al.  Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. , 2003, Biochemistry.

[147]  D. Kabat,et al.  Cooperation of Multiple CCR5 Coreceptors Is Required for Infections by Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.

[148]  P. Bugelski,et al.  Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120 , 1993, Journal of virology.

[149]  C. Voisset,et al.  Functional hepatitis C virus envelope glycoproteins , 2004, Biology of the cell.

[150]  L. Ratner,et al.  Actin Cytoskeletal Reorganizations and Coreceptor-Mediated Activation of Rac during Human Immunodeficiency Virus-Induced Cell Fusion , 2004, Journal of Virology.

[151]  Michael D. Miller,et al.  Low pH Is Required for Avian Sarcoma and Leukosis Virus Env-Dependent Viral Penetration into the Cytosol and Not for Viral Uncoating , 2004, Journal of Virology.

[152]  D. Griffin,et al.  Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins , 2005, The Journal of cell biology.

[153]  K. Salzwedel,et al.  Sequential CD4-Coreceptor Interactions in Human Immunodeficiency Virus Type 1 Env Function: Soluble CD4 Activates Env for Coreceptor-Dependent Fusion and Reveals Blocking Activities of Antibodies against Cryptic Conserved Epitopes on gp120 , 2000, Journal of Virology.

[154]  E. Freed HIV-1 and the host cell: an intimate association. , 2004, Trends in microbiology.

[155]  H. I. Henderson,et al.  The temperature arrested intermediate of virus-cell fusion is a functional step in HIV infection , 2006, Virology Journal.

[156]  J. Moore,et al.  Human Immunodeficiency Virus Type 1 Env with an Intersubunit Disulfide Bond Engages Coreceptors but Requires Bond Reduction after Engagement To Induce Fusion , 2003, Journal of Virology.

[157]  Y. Gaudin Rabies Virus-Induced Membrane Fusion Pathway , 2000, The Journal of cell biology.

[158]  Ari Helenius,et al.  How Viruses Enter Animal Cells , 2004, Science.

[159]  T. Vorherr,et al.  H+-induced Membrane Insertion of Influenza Virus Hemagglutinin Involves the HA2 Amino-terminal Fusion Peptide but Not the Coiled Coil Region* , 1996, The Journal of Biological Chemistry.

[160]  P. Earl,et al.  The ectodomain of HIV‐1 env subunit gp41 forms a soluble, alpha‐helical, rod‐like oligomer in the absence of gp120 and the N‐terminal fusion peptide. , 1996, The EMBO journal.

[161]  F. Rey,et al.  Virus membrane-fusion proteins: more than one way to make a hairpin , 2006, Nature Reviews Microbiology.

[162]  M. Kozlov,et al.  Lipids in biological membrane fusion , 1995, The Journal of Membrane Biology.

[163]  G. Melikyan,et al.  Membrane-Anchored Inhibitory Peptides Capture Human Immunodeficiency Virus Type 1 gp41 Conformations That Engage the Target Membrane prior to Fusion , 2006, Journal of Virology.

[164]  David H. Schwartz,et al.  Actin-Dependent Receptor Colocalization Required for Human Immunodeficiency Virus Entry into Host Cells , 1998, Journal of Virology.

[165]  V. Robert-Hebmann,et al.  The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through Gαi-protein signalling , 2006, AIDS.

[166]  P. Bronk,et al.  The Pathway of Membrane Fusion Catalyzed by Influenza Hemagglutinin: Restriction of Lipids, Hemifusion, and Lipidic Fusion Pore Formation , 1998, The Journal of cell biology.

[167]  P. Bates,et al.  Heptad Repeat 2-Based Peptides Inhibit Avian Sarcoma and Leukosis Virus Subgroup A Infection and Identify a Fusion Intermediate , 2004, Journal of Virology.

[168]  X. Zhuang,et al.  Virus trafficking – learning from single-virus tracking , 2007, Nature Reviews Microbiology.

[169]  C. Broder,et al.  Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. , 2004, Blood.

[170]  S. Günther,et al.  Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1 , 1995, Journal of virology.

[171]  M. Kielian,et al.  Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein , 1991, Journal of virology.

[172]  J. Young,et al.  Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[173]  P. S. Kim,et al.  HIV Entry and Its Inhibition , 1998, Cell.

[174]  C. Bewley,et al.  Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. , 2005, Biochemistry.

[175]  S. Zolla-Pazner,et al.  Dissection of Human Immunodeficiency Virus Type 1 Entry with Neutralizing Antibodies to gp41 Fusion Intermediates , 2002, Journal of Virology.

[176]  R. Dutch,et al.  Role of the Simian Virus 5 Fusion Protein N-Terminal Coiled-Coil Domain in Folding and Promotion of Membrane Fusion , 2005, Journal of Virology.

[177]  C. Martínez-A,et al.  Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity , 2004, The Journal of experimental medicine.